| Catalog Number |
07251670190 |
| Medical Device Problem Code |
Incorrect Measurement (1383)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
07/21/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The e801 analyzer serial number was (b)(6).Sample material was received for investigation and tested on an e801 analyzer with anti-ccp reagent lot number: 860040.The result was 233 u/ml.The customer's results were reproduced at the investigation site.The investigation is ongoing.
|
| |
|
Event or Problem Description
|
|
We received an allegation of questionable high results not corresponding to the clinical picture for 1 patient tested for elecsys anti-ccp (anti-ccp) on a cobas e 801 analytical unit.On (b)(6) 2025, the result from the e801 analyzer was 217 u/ml.This sample was sent to an external laboratory using the thermo fisher method, and the result was "in the reference range." the specific result was not provided.On (b)(6) 2025, a new sample was obtained, and the result from the e801 analyzer was 235 u/ml.On (b)(6) 2025, the repeat result from the e801 analyzer was 236 u/ml.This sample was sent to an external laboratory using the thermo fisher method, and the result was 1 u/ml (reference range 0 ¿ 10 u/ml).
|
| |
|
Additional Manufacturer Narrative
|
|
Upon further investigation of the patient sample, an interferent against the streptavidin component of the reagent was confirmed.This interference is covered in product labeling: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design." the investigation did not identify a product problem.
|
| |
|
Search Alerts/Recalls
|